TrialPloS one2013

A randomised, placebo-controlled, first-in-human study of a novel clade C therapeutic peptide vaccine administered ex vivo to autologous white blood cells in HIV infected individuals.

Akil Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.